Initial observations from clinical retinoblastoma pathological sections revealed a consistent expression trend, wherein the levels of ATF4 and ARL5B were both lower in normal para-cancerous retinal tissues compared to RB tumor tissues. This evidence concerns the gene ARL5B and neoplasm.